¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pharmacoepidemiology and drug safety."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
¿µ¹® antihypertensive drug ÇÑ±Û °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
¼³¸í   
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ »ç¿ëÇϸ砳ôÀº Ç÷¾ÐÀ» ³·Ãߴ ¾à¹°À» ¸»ÇÑ´Ù. °íÇ÷¾Ð¾à¿¡´Â Ç÷°üÆòȰ±Ù¿¡ Á÷Á¢ ÀÛ¿ëÇÏ¿© À̿ϽÃ۴ Ç÷°üÈ®ÀåÁ¦(È÷µå¶ó¶óÁø), ±³°¨½Å°æÀǠȰµ¿À» ¾îµð¼±°¡ Â÷´ÜÇϴ ¾à¹°(·¹¼¼¸£ÇÉ, ¸ÞÆ¿µµÆÄ, ÇÁ·ÎÇÁ¶ó³ë·Ñ), ÀÌ´¢Á¦(ÇÁ·Î¼¼¹Ìµå, ¿¡Å¸Å©¸°»ê)ÀÌ »ç¿ëµÈ´Ù.
¿µ¹® antimalarial drug ÇÑ±Û ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
¼³¸í   
  ¸»¶ó¸®¾Æ Ä¡·á¿¡ ¾²´Â ¾à. Å°´Ï³×, Å¬·Î·ÎÄý, ÇÁ¸®¸¶Äý µûÀ§°¡ ÀÖ´Ù. ¸»¶ó¸®¾Æ ¿øÃæÀÇ ¹ßÀ°Áֱ⿡ ´ëÀÀÇØ¼­ ¾à¹°ÀÌ ÀÖÀ¸³ª ´ëºÎºÐÀº º´¿ë¿ä¹ý¿¡ µû¶ó¼­ ¸»¶ó¸®¾Æ Ä¡·á¸¦ ÇÑ´Ù. ¸ð±â¿¡ ÀÇÇÑ Æ÷ÀÚü°¨¿°¿¡ ´ëÇÑ Çׯ÷ÀÚü ¾àÀº µ¶¼º µîÀÇ ¹®Á¦°¡ À־ ¾ÆÁ÷ ¾ø´Ù. ÀûÇ÷±¸³»¿¡¼­ÀǠȯ»óü, ¹ø½Äü¿¡¸¸ ÀÛ¿ëÇϴ °Í(Ç×¹ø½Äü ¾àÀº Å¬·Î·ÎÄý, ÇǸ®¸ÞŸ¹Î, Å¬·Î·Î±¸¾Æ³ªÀ̵å, Å°´Ï³×)Àº ÀûÇ÷±¸ ¿ÜÀÇ ¹ßÀ°Àº ¾ïÁ¦ÇÏÁö ¾ÊÀ¸¹Ç·Î °¨¿°À» ¿ÏÀüÈ÷ ÀúÁöµÇÁö ¾Ê´Â´Ù. ÀûÇ÷±¸³»¿ÜÀÇ ¿øÃæ¿¡ ÀÛ¿ëÇØ ¿ÏÀüÈ÷ °¨¿°À» ¾ïÁ¦Çϴ °Í(ÆÄ¸¶Å², ÆæÅ¸Å², ÇÁ¸®¸¶Å²), Ç÷ÁßÀÇ »ý½Äü¸¦ Á×À̴ °Í(´ëºÎºÐÀÇ Ç׸»¶ó¸®¾ÆÁ¦)Àº ¸ð±â¿¡ ÀÇÇѠŸÀÎÀ¸·ÎÀÇ Àü¿°¿øÀº ²÷±â´Âµ¥ È¯ÀÚÀÚ½ÅÀÇ Áõ»óÀº º¯È­ÇÏÁö ¾Ê´Â´Ù.
¿µ¹® drug ÇÑ±Û ¾à, ¾à¹°, ¾àÁ¦
¼³¸í   
  1. º´, ±âŸ º´Àû »óÅÂÀÇ Áø´Ü, Ä¡·á, ¿¹¹æÀ̳ª °íÅëÀÇ °æ°¨, ¶Ç´Â »ý¸®Àû, º´¸®Àû »óŸ¦ È£Àü½Ã۴ °ÍÀ» ¸ñÀûÀ¸·Î »ç¶÷ ¶Ç´Â µ¿¹°¿¡ Åõ¿©µÇ´Â È­ÇÕ¹°. ¾à¸®Çп¡¼­´Â Ä¡·á¾à¸¸ÀÌ ¾Æ´Ï¶ó, »ýü¿¡ ÁÖ¾îÁ³À» ¶§ ¾î¶°ÇÑ ¹ÝÀÀÀ» ³ªÅ¸³»´Â È­Çй°Áú ¸ðµÎ¸¦ ¾à¹°À̶ó°í ÇÑ´Ù. ÀÛ¿ëÀÌ °­ÇÏ°í ¾ÈÀü¼ºÀÌ ³·Àº ¼ø¼­·Î µ¶¾à-±Ø¾à-º¸Åë¾àÀ¸·Î ±¸ºÐÇϰí ÀÖ´Ù. ¾à¹°Ä¡·á¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀÎÀڷμ­, »ýüÂÊ ÀÎÀڷδ °³Ã¼Â÷, ¿¬·É, Ã¼Áß µîÀÌ ÀÖ°í, ¾à¹°ÂÊ ÀÎÀڷμ­´Â Åõ¿©¹æ¹ý, Åõ¿©·®, º´¿ëµÇ°í Àִ ´Ù¸¥ ¾à¹° µîÀÌ ÀÖ´Ù. 2. ¾àÀÇ Àç·á°¡ µÇ´Â ¹°Áú. 3. ¿©·¯ °¡Áö ¾àÀ縦 ¼¯¾î Á¶Á¦ÇÑ ¾à.
¿µ¹® drug resistance ÇÑ±Û ¾à¹°³»¼º
¼³¸í   
  1. È­Çпä¹ýÁ¦³ª Ç×»ý¹°ÁúÀÇ ¾î¶² ÀÏÁ¤ ³óµµ·Î ¼¼±ÕÀ» Á×À̰ųª Áõ½ÄÀúÇØ¸¦ ¹Þ´Â °ÍÀ» ÀÌ È­Çпä¹ýÁ¦³ª Ç×»ý¹°Áú¿¡ °¨¼ö¼ºÀÌ ÀÖ´Ù°í Çϴµ¥, ÀÌ °¨¼ö¼ºÀÌ ¾ø°Ô µÈ »ýŸ¦ ÀúÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. µû¶ó¼­ º¯À̹̻ý¹°ÀÇ ¾àÁ¦¿¡ ´ëÇÑ ÀÚÇ×¼ºÀ̶óµç°¡ ³»¼ºÀ̶ó°í ¸»ÇÑ´Ù. 2. ÀǾàǰÀ» °è¼Ó º¹¿ëÇϸé Á¡Â÷ Áõ·®ÇÏÁö ¾ÊÀ¸¸é È¿·ÂÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ¼ºÁú. ÀÌ·¯ÇÑ ¶§¸¦ ¾àÁ¦³»¼ºÀÌ »ý°å´Ù°í ÇÑ´Ù. ¸ðµç ¹Ì»ý¹°Àº °¨¼ö¼ºÀ» °¡Áö´Â ¾à¹°¿¡ ÀÇÇÏ¿© »ç¸êµÇÁö¸¸, ¼Ò¼öÀÇ °ÍÀº »ì¾Æ³²¾Æ ±×°ÍÀÌ ÁøÈ­µÊÀ¸·Î½á »ç¸êÇÏÁö ¾Ê´Â ¼ö°¡ ÀÖ´Ù. ¶Ç, ÃÖÃÊ¿¡´Â °¨¼ö¼ºÀ» °¡Áö°í ÀÖ´ø ±ÕÀÌ Â÷Â÷ ³»¼º±ÕÀ¸·Î µÇ±âµµ ÇÑ´Ù. ¸¹Àº º´¿ø±ÕÀº °¨¼ö¼ºÀÌ Àִ ÀǾàǰ¿¡ ´ëÇÏ¿© ³»¼ºÀÌ »ý±ä´Ù. °¡Àå °íµµÀÇ ³»¼º±ÕÀÌ »ý±â±â ½¬¿î °ÍÀº ½ºÆ®·¾Å丶À̽ÅÀε¥ °áÇÙ±Õ°ú ±×¶÷À½¼º±Õ¿¡ ´ëÇÏ¿© ½±°Ô ³»¼ºÀÌ »ý±ä´Ù. Æä´Ï½Ç¸°À̳ª Åׯ®¶ó½ÃŬ¸°(¾ÆÅ©·Î¸¶À̽Å) µîÀÇ Ç×»ý¹°Áúµµ ³»¼ºÀÌ »ý±â±â ½¬¿ì¹Ç·Î, »ç¿ëÇÒ ¶§´Â ÀûÀÀÀ» Àß È®ÀÎÇÏ¿© Çʿ䷮À» Á¤ÇÏ°í ¿¬¿ëÀ» ÇÇÇÑ´Ù. °°Àº È¿°ú°¡ Àִ ´Ù¸¥ Á¾·ùÀÇ ¾àÁ¦¸¦ ¼Ò·®¾¿ 2, 3Á¾ º´¿ëÇϸ頳»¼ºÀÇ ¹ß»ýÀÌ Å©°Ô ¾ïÁ¦µÈ´Ù´Â °ÍÀÌ ¾Ë·ÁÁ® ÀÖ´Ù. °áÇÙ¾àÀ¸·Î¼­ ½ºÆ®·¾Å丶À̽Űú ÆÄ½º, ¶Ç´Â À̼ҴϾÆÁöµå¸¦ º´¿ëÇϴ °Í µîÀÌ ±× ¿¹ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pharmacoepidemiology
    ¾à¸®¿ªÇÐ
  • biological safety cabinet
    »ý¹°ÇÐÀû¾ÈÀü½ÇÇè´ë
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety
    1. ¾ÈÀü 2. ¾ÈÀü¼º
  • safety control
    ¾ÈÀü°ü¸®
  • safety factor
    ¾ÈÀü°è¼ö
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
  • arch and band appliance
    Ȱ¶ìÀåÄ¡
  • bilateral cleft lip and palate
    ¾çÂÊÀÔ¼úÀÔõÀå°¥¸²Áõ, ¾çÃø±¸¼ø±¸°³¿­
  • bread-and-butter pericarditis
    »§¹öÅ͸ð¾ç½ÉÀ帷¿°
  • complementary and alternative medicine
    º¸Ãæ´ë¾ÈÀÇÇÐ, º¸¿Ï´ëüÀÇÇÐ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
  • dilatation and curettage
    Àڱñܾ(¼ú), ÀÚ±Ã¼ÒÆÄ(¼ú)
  • foot-and-mouth disease
    ÀԹߺ´, ±¸Á¦¿ª
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • safety control
    ¾ÈÀü°ü¸®
  • safety
    ¾ÈÀü, ¾ÈÀüµµ
  • safety standard
    ¾ÈÀü±âÁØ
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • antiamebic drug
    ¾Æ¸Þ¹Ù¾à, Ç׾Ƹ޹ÙÁ¦
  • antiarrhythmic drug
    ºÎÁ¤¸Æ¾à, Ç׺ÎÁ¤¸ÆÁ¦
  • anticoagulant drug
    Ç×ÀÀ°íÁ¦
  • antiemetic drug
    ±¸Åä¾à, Ç×±¸ÅäÁ¦
  • antihistaminic drug
    Ç×È÷½ºÅ¸¹ÎÁ¦
  • antihypertensive drug
    °íÇ÷¾Ð¾à, Ç×°íÇ÷¾ÐÁ¦
  • antimalarial drug
    ¸»¶ó¸®¾Æ¾à, Ç׸»¶ó¸®¾ÆÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pharmacoepidemiology
    ¾à¸®¿ªÇÐ
  • biological safety cabinet
    »ý¹°ÇÐÀû¾ÈÀü½ÇÇè´ë
  • safety cabinet
    ¹«±Õ½ÇÇè´ë
  • safety control
    ¾ÈÀü°ü¸®
  • safety factor
    ¾ÈÀü°è¼ö
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • MR safety
    ÀÚ±â°ø¸í¾ÈÀüµµ
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety
    ¾ÈÀü, ¾ÈÀüµµ
  • safety standard
    ¾ÈÀü±âÁØ
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
  • arch and band appliance
    Ȱ¶ìÀåÄ¡
  • split pin and tube attachment
    À¯ÃʺÐÇÒÇÕÁ¤
  • babbling and lalling stage
    ¿Ë¾ËÀ̽ñâ
  • bilateral cleft lip and palate
    ¾çÂÊÀÔ¼úÀÔõÀå°¥¸²Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • MR safety
    ÀÚ±â°ø¸í ¾ÈÀüµµ
  • MSDS => Material Safety Data Sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • pop valve =safety v.
    ¾ÈÀüÆÇ(äÌîï÷û).
  • protective spectacles =safety goggles
    ¹æÈ£¾È°æ(ËÑÌ´ËâË­).
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • DSM-I=Diagnostic and Statistical Manual of Mental Disorders-I
    Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 1ÆÇ
  • Death and dying
    »ç¸Á°úÀÓÁ¾
  • ENT =ear, nose and throat
    À̺ñÀÎÈİú(ÇÐ)
  • General anesthesia, reticular activating system and.
    Àü½Å¸¶Ãë(îïãóئö­), ¸Á»óüȰ¼ºÈ­°è(ØÑßÒô÷üÀàõûùͧ)
  • Gravity, cardiac output and
    Áß·Â(ñìÕô), ½É¹ÚÃâ·®(ãýÚÑõóÕá)
  • KUB= kidney, ureter and bladder
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • PACS (picture archiving and communicating system)
    ÆÑ½º, ¿µ»ó ÀúÀå ¹× Àü¼Û ü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pharmacoepidemiology
    ¾à¹°¿ªÇÐ.
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • papilomatosis of Gougerot and Carteaud => confluent and reticulated pa
  • biological safety cabinet
    »ý¹°ÇÐÀû ¾ÈÀüÇÔ(ùÞ)
  • margin of safety
    ¾ÈÀü¿ª.
  • maximum safety pressure
    ÃÖ´ë¾ÈÀü¾Ð.
  • minimum safety pressure
    ÃÖ¼Ò¾ÈÀü¾Ð.
  • pop valve =safety v.
    ¾ÈÀüÆÇ(äÌîï÷û).
  • protective spectacles =safety goggles
    ¹æÈ£¾È°æ(ËÑÌ´ËâË­).
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety cabinet
    ¹«±Õ½ÇÇè´ë, ¾ÈÀü½ÇÇè´ë
  • safety control
    ¾ÈÀü°ü¸®(ËâËøË´Ëö).
  • safety factor
    ¾ÈÀüÀ².
  • safety lens
    ¾ÈÀü·»Áî
  • safety precaution
    ¾ÈÀüÁöħ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiamebic drug
    ¾Æ¸Þ¹Ù±¸ÃæÁ¦
  • antimalarial drug
    Ç׸»¶ó¸®¾ÆÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • drug resistance
    ¾à¹° ÀúÇ×(å·Úªî½ù÷)
  • drug-resistance plasmid
    ¾à¹°ÀúÇ×(å·Úªî½ù÷) Çö󽺹̵å (ÔÒ) R plasmid
  • narcotic drug
    ¸¶¾à(ئå·)
  • psychedelic drug
    ȯ°¢Á¦(ü³ÊÆð¥)
  • radiomimetic drug
    ¹æ»ç¼± ¾ç(À¯»ç) ¾à¹°(Û¯ÞÒàÊåÆ(ëºÞÄ)å·Úª)
  • sulfa drug
    ¼³ÆÄÁ¦(ð¥)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
  • "Koshland, Nemethy, and Filmer model"
    "ÄÚ½¬·»µå,³×¸ÞƼ,ÇÊ¸Ó ¸ðµ¨"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MR safety
    ÀÚ±â°ø¸í¾ÈÀüµµ
  • safety
    ¾ÈÀü(¼º)
  • safety margin
    ¾ÈÀü¿ª, ¾ÈÀüÇѰè
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • drug abuse
    ¾à¹°³²¿ë
  • narcotic drug
    ¸¶¾à
  • tuberculostatic drug
    Ç×°áÇÙ¾à
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • PACS [=picture archiving and communicating system]
    ÆÑ½º, ¿µ»óÀúÀå ¹× Àü¼Ûü°è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DA dark adaptation; dark agouti [rat]; daunomycin; degenerative arthritis; delayed action; Dental Assis...
IDSAN International Drug Safety Advisory Network
RADS reactive airways dysfunction syndrome; retrospective assessment of drug safety
DAST drug abuse screening test; drug and alcohol screening test
ALOSH Appalachian Laboratory for Occupational Safety and Health
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ESSENCE Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events
FSIS Food Safety and Inspection Service
HSE Health and Safety Executive
MSHA Mine Safety and Health Administration
NIOSH National Institute for Occupational Safety and Health
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 22236
    JournalTitle: Pharmacoepidemiology and drug safety.
    MedAbbr: Pharmacoepidemiol Drug Saf
    ISSN: 1053-8569
    ESSN:
    IsoAbbr:
    NlmId: 9208369
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • safety regulation and standard
    ¾ÈÀü Á¶Àý ¹× Ç¥ÁØ
  • Food and Drug Administration
    ½ÄǰÀǾà±â±¸
  • biological safety cabinet
    »ý¹°ÇÐÀû ¾ÈÀüÇÔ
  • hospital laser safety officer
    º´¿øÀÇ ·¹ÀÌÀú ¾ÈÀü °ü¸®ÀÚ
    ÀÇÇÐ ºÐ¾ß¿¡¼­ ·¹ÀÌÀúÀÇ ¾ÈÀüÇÑ Á¶ÀÛÀ» ¼öÇàÇϴµ¥ ÇÊ¿äÇÑ ¸ðµç ¹æ¹ýÀ» °ü¸® Á¶ÀýÇÏ´Â »ç¶÷.
  • laser safety officier
    ·¹ÀÌÀú ¾ÈÀü°ü¸®ÀÚ
    Ư¼öÇÑ °Ç°­ °ü¸® Àåºñ¸¦ ´Ù·ç´Â ¸ðµç »ç¶÷¿¡ ´ëÇÑ ±³À°°ú ÈÆ·ÃÀ» ´Ù·ç°í ÀÖ´Â ·¹ÀÌÀú ¾ÈÀü ÇÁ·Î±×·¥À» °ü¸®ÇÏ°í ¼öÇàÇÏ´Â »ç¶÷.
  • margin of safety
    ¾ÈÀü ¿ª
  • MR safety
    Àڱ⠰ø¸í ¾ÈÀüµµ
  • safety
    ¾ÈÀü, ¾ÈÁ¤¼º
  • safety education
    ¾ÈÀü ±³À°
    ¾ÈÀüÇÑ »ýȰÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÊ¿äÇÑ Áö½ÄÀ» ÁÖ´Â °Í.
  • safety factor
    ¾ÈÀü·ü
    ½Å°æ ¼¶À¯³ª ±Ù¼¶À¯ÀÇ ÈïºÐ Á¤µµ¿¡ À־ ÀÌ¹Ì ÈïºÐÇÑ °÷¿¡¼­, ¾ÆÁ÷ ÈïºÐÇϰí ÀÖÁö ¾ÊÀº ºÎºÐÀ¸·Î Àü·ù°¡ È帧À¸·Î½á ÈïºÐÀÌ ÀüµµÇϴµ¥, ÀÌ Àü·ù°¡ ½ÇÁ¦·Î ÈïºÐ½Ã۴µ¥ ÇÊ¿äÇÑ Àü·ù°ª.
  • safety inspection
    ¾ÈÀü °¨½Ã
    ¸ðµç »ýȰ ȯ°æ¿¡¼­ ¾ÈÀü °ü¸®¸¦ ¸ñÀûÀ¸·Î ÇÑ´Ù. ÀÏ¹Ý »ýȰ ȯ°æ, ³ëµ¿ ȯ°æ ¹× Çб³ ȯ°æ µî, ¸ðµç »ýȰ ȯ°æ¿¡¼­ÀÇ ¾ÈÀü °ü¸®¸¦ ¸ñÀûÀ¸·Î ÀÏ¹Ý °øÁß À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â º¸°Çº¹ÁöºÎ°¡, ³ëµ¿À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â ³ëµ¿ºÎ°¡, Çб³À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â ±³À°ºÎ°¡ Áß½ÉÀÌ µÇ¾î ȯ°æ °¨½Ã Ȱµ¿À» Çϰí ÀÖ´Ù.
  • safety measure
    ¾ÈÀüÃ¥
  • safety pipetter
    ¾ÈÀü ÇÇÆäÅÍ
    ¾×üÀÇ À̵¿À» ¶³¾îÁ®¼­ ÇàÇϱâ À§ÇØ »ç¿ëÇÏ´Â ÇÇÆê.
  • safety supervisor
    ¾ÈÀü °ü¸®ÀÚ
    ³ëµ¿¾ÈÀü À§»ý¹ýÀ¸·Î ¼±ÀÓµÈ ¾ÈÀüº¸¾È ´ã´çÀÚ.
  • safety valve
    ¾ÈÀü ÆÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
pharmacoepidemiology The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (pharmacoepidemiol drug saf 1992;1(1); j pharmacoepidemiol 1990;1(1))
(12 Dec 1998)
national institute for occupational safety and health An institute of the centres for disease control and prevention which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals.
(12 Dec 1998)
occupational safety and health administration One of the U.S. Agencies responsible for regulation of biotechnology. The major law under which the agency has regulatory powers is the Occupational Safety and Health act.
(09 Oct 1997)
united states occupational safety and health administration An office in the department of labour responsible for developing and establishing occupational safety and health standards.
(12 Dec 1998)
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
drug and narcotic control Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (drug approval), and marketing of drugs.
(12 Dec 1998)
united states food and drug administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
(12 Dec 1998)
food and drug administration The U.S. Agency responsible for regulation of biotechnology foodproducts. The major laws under which the agency has regulatory powersinclude the Food, Drug, and Cosmetic act, and the Public Health Service Act.
(09 Oct 1997)
margin of safety The margin between the minimal therapeutic dose and the minimal toxic dose of a drug.
(05 Mar 2000)
safety 1. The condition or state of being safe; freedom from danger or hazard; exemption from hurt, injury, or loss. "Up led by thee, Into the heaven I have presumed, An earthly guest . . . With like safety guided down, Return me to my native element." (Milton)
2. Freedom from whatever exposes one to danger or from libility to cause danger or harm; safeness; hence, the quality of making safe or secure, or of giving confidence, justifying trust, insuring against harm or loss, etc. "Would there were any safety in thy sex, That I might put a thousand sorrows off." (Beau. & Fl)
3. Preservation from escape; close custody. "Imprison him, . . . Deliver him to safety; and return." (Shak)
4. Same as Safety touchdown, below.
<chemistry> Safety arch, a tube to prevent explosion, or to control delivery of gases by an automatic valvular connection with the outer air; especially, a bent funnel tube with bulbs for adding those reagents which produce unpleasant fumes or violent effervescence. Safety valve, a valve which is held shut by a spring or weight and opens automatically to permit the escape of steam, or confined gas, water, etc, from a boiler, or other vessel, when the pressure becomes too great for safety; also, sometimes, a similar valve opening inward to admit air to a vessel in which the pressure is less than that of the atmosphere, to prevent collapse.
Origin: Cf. F. Sauvete.
Source: Websters Dictionary
(01 Mar 1998)
safety factor <radiobiology> The number of times a field line goes around a torus the long way for each time around the short way.
In a tokamak, this number is typically near unity in the centre of the plasma and between two and 6 or 8 at the edge. So-called because it helps to determine the degree of stability the plasma has against certain instabilities. The safety factor is the inverse of the rotational transform, and can be expressed mathematically as q = (r Bt)/(R Bp), where r and R are the minor and major radii of the torus, and Bt and Bp are the toroidal and poloidal magnetic fields.
(17 Dec 1997)
safety lens A lens that meets government specifications of impact resistance; the increased impact resistance required for safety lens's is obtained by tempering, by an ion-exchange process, or by using laminated or plastic lenses.
(05 Mar 2000)
safety management The development of systems to prevent accidents, injuries, and other adverse occurrences in an institutional setting. The concept includes prevention or reduction of adverse events or incidents involving employees, patients, or facilities. Examples include plans to reduce injuries from falls or plans for fire safety to promote a safe institutional environment.
(12 Dec 1998)
safety spectacles Spectacles which protect against ultraviolet or infrared rays or against mechanical injuries.
Synonym: safety spectacles.
(05 Mar 2000)
safety strap <dentistry> A plastic strap which prevents a face-bow from coming loose and hurting you.
(08 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
  • safety
    ¾ÈÀü
  • combination drug
    º¹ÇÕ¾à(2Á¾ ÀÌ»óÀÇ Ç×»ý ¹°Áú µîÀÇ È¥ÇÕ¾à)
  • counter drug
    ÀÇ»çÀÇ Ã³¹æ ¾øÀÌ ÆÇ¸ÅµÇ´Â ¾à
  • drug
    ¾à;¾àÁ¦;¾àǰ;¸¶¾à;~¿¡ ¾àÀ»³Ö´Ù;¸¶Ãë½ÃŰ´Ù;¹°¸®°ÔÇÏ´Ù
  • drug addict
    ¸¶¾à Áßµ¶ÀÚ
  • drug buster
    (¹Ì)¸¶¾à ´Ü¼Ó°ü 
  • drug design
    (¾à)¾àÁ¦ ¼³°è(À¯È¿¼ºÀ» ³ôÀ̱â À§ÇÑ Á¾ÇÕÀû °³¹ß °ËÅä
  • drug interaction
    (¾à)¾à¹° »óÈ£ ÀÛ¿ë
  • drug pump
    (ÀÇ)¾à ÆßÇÁ(Ç÷°ü ÁÖ»ç¿ë)
  • fertillity drug
    ÀӽŠÃËÁøÁ¦
  • free safety
    ÇÁ¸® ¼¼ÀÌÇÁƼ
  • garbage drug
    ¿ªÈ¿°ú¸¦ ÃÊ·¡Çϱ⠽¬¿î ¸¶¾à(Á¢ÂøÁ¦³ª ½Ã³Ê µî)
  • hard drug
    ½À°ü¼º ¸¶¾à
  • miracle drug
    Ưȿ¾à;¿µ¾à
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á